Bristol-Myers Squibb Co - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
BMY New York 2834 http://www.bms.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Bristol-Myers Squibb Co

Bristol-Myers Posts Data on Empliciti, China Approves Opdivo - Jun 18th, 2018 4:23 pm
Eight Stocks That Are Poised to Change Direction - Jun 18th, 2018 1:00 pm
5 Drug Stocks With Fat Payouts - Jun 18th, 2018 4:00 am
Empliciti (elotuzumab) Plus Pomalidomide and Low-Dose Dexamethasone Reduces the Risk of Disease Progression by 46% Versus Pomalidomide/Dexamethasone Alone in Patients with Relapsed or Refractory Multiple Myeloma - Jun 17th, 2018 4:30 am
Cash for NASH: 2 Top Biotech Takeover Targets and 3 Potential Buyers - Jun 15th, 2018 12:31 pm
China National Drug Administration Approves Country’s First Immuno-Oncology Agent, Opdivo (nivolumab injection), for Previously Treated Non-Small Cell Lung Cancer (NSCLC) - Jun 15th, 2018 6:32 am
Bristol-Myers Squibb Announces Dividend - Jun 14th, 2018 2:30 pm
Bristol-Myers Squibb to Present New Research Findings on the Treatment of Patients with Early Rheumatoid Arthritis at the Annual European Congress of Rheumatology (EULAR 2018) - Jun 13th, 2018 4:00 am
Does Bristol-Myers Squibb Company’s (NYSE:BMY) PE Ratio Signal A Selling Opportunity? - Jun 12th, 2018 3:32 pm
Bristol-Myers Squibb to Take Part in Goldman Sachs 39th Annual Global Healthcare Conference - Jun 11th, 2018 2:45 pm
Fred Hutch leases iconic Lake Union Steam Plant facility - Jun 11th, 2018 7:29 am
The Zacks Analyst Blog Highlights: Bristol Myers, Merck, Roche, Lilly and AbbVie - Jun 11th, 2018 7:08 am
Pharma Stock Roundup: MRK Impresses at ASCO, LLY Gets FDA Nod for Olumiant - Jun 8th, 2018 8:27 am
See what the IHS Markit Score report has to say about Bristol-Myers Squibb Co. - Jun 8th, 2018 6:01 am
Why Nektar Therapeutics Stock Stumbled 11.8% Today - Jun 7th, 2018 7:09 pm
Bristol-Myers Squibb to Announce Results for Second Quarter 2018 on July 26 - Jun 7th, 2018 4:59 am
Here's Why Nektar Therapeutics Jumped as Much as 17% Today - Jun 6th, 2018 2:15 pm
ASCO Ends: Winners & Losers at the Key Cancer Research Event - Jun 6th, 2018 6:29 am
Nektar Therapeutics Stock Is a Buy After a Major Market Misread - Jun 5th, 2018 9:00 am
Nektar (NKTR) and Bristol-Myers Present Data on Cancer Study - Jun 5th, 2018 6:42 am